Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | C100 - Diagnosis and Treatment of Functional Movement Disorders

Monday 04/15/24
03:30 PM - 05:30 PM MDT Add To Calendar
Colorado Convention Center | Bluebird 1A
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Sarah C. Lidstone, MD, PhD
Movement Disorders
Participants should learn to recognize the history and examination features that indicate a diagnosis of FMD, understand the common perpetuating factors that maintain functional symptoms including stress, and apply FMD treatment principles in their practice both at the bedside and/or through referral to a multidisciplinary team.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:00 PM MDT Speaker Recognition and Diagnosis of Functional Movement Disorder
Alberto J. Espay, MD, FAAN
04:00 PM - 04:30 PM MDT Speaker Clinically Relevant Mechanisms in Functional Movement Disorder
Selma Aybek, MD, FAAN
04:30 PM - 05:00 PM MDT Speaker Practical Treatment Strategies in Functional Movement Disorder
Sarah C. Lidstone, MD, PhD
05:00 PM - 05:30 PM MDT Q&A Discussion
Sarah C. Lidstone, MD, PhD, Selma Aybek, MD, FAAN, Alberto J. Espay, MD, FAAN
Faculty Disclosures
Sarah C. Lidstone, MD, PhD Dr. Lidstone has received publishing royalties from a publication relating to health care.
Selma Aybek, MD, FAAN Dr. Aybek has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Swiss Movement Disorder Foundation. The institution of Dr. Aybek has received research support from Swiss National Science Foundation.
Alberto J. Espay, MD, FAAN Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus (formerly, USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avion Pharmaceuticals. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.